125 related articles for article (PubMed ID: 29426774)
21. Characterization of clinical multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolates, 2007-2009, China.
Zhang Y; Yang J; Ye L; Luo Y; Wang W; Zhou W; Cui Z; Han L
Microb Drug Resist; 2012 Oct; 18(5):465-70. PubMed ID: 22548669
[TBL] [Abstract][Full Text] [Related]
22. [Trend in the susceptibility of the most frequent bacterial pathogens isolated at Hospital General La Mancha Centro over 2010-2012 period].
Asencio MÁ; Huertas M; Carranza R; Franco M; Castellanos J; Barberá JR; Conde Mdel C; Tenías JM
Rev Esp Quimioter; 2014 Dec; 27(4):261-8. PubMed ID: 25536430
[TBL] [Abstract][Full Text] [Related]
23. Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli.
Gomez L; Garau J; Estrada C; Marquez M; Dalmau D; Xercavins M; Martí JM; Estany C
Cancer; 2003 Jan; 97(2):419-24. PubMed ID: 12518366
[TBL] [Abstract][Full Text] [Related]
24. Ciprofloxacin prophylaxis in children with acute leukemia in an era of increasing antibiotic resistance.
Castagnola E; Moroni C; Bandettini R; Caprino D; Haupt R
Pediatr Infect Dis J; 2013 May; 32(5):581. PubMed ID: 23838665
[No Abstract] [Full Text] [Related]
25. [Aspects of the antimicrobial resistence profile in infections with Escherichia coli and Klebsiella pneumoniae in diabetic patients].
Petrovici CG; Dorobăţ C; Matei M; Teodor A; Luca V; Miftode E
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):769-75. PubMed ID: 22046785
[TBL] [Abstract][Full Text] [Related]
26. Antibiotic Prophylaxis Is Associated with Subsequent Resistant Infections in Children with an Initial Extended-Spectrum-Cephalosporin-Resistant Enterobacteriaceae Infection.
Das S; Adler AL; Miles-Jay A; Kronman MP; Qin X; Weissman SJ; Burnham CA; Elward A; Newland JG; Selvarangan R; Sullivan KV; Zaoutis T; Zerr DM
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289030
[TBL] [Abstract][Full Text] [Related]
27. Time-kill synergy tests of tigecycline combined with imipenem, amikacin, and ciprofloxacin against clinical isolates of multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
Yim H; Woo H; Song W; Park MJ; Kim HS; Lee KM; Hur J; Park MS
Ann Clin Lab Sci; 2011; 41(1):39-43. PubMed ID: 21325253
[TBL] [Abstract][Full Text] [Related]
28. In vitro antimicrobial susceptibility of Escherichia coli isolates from clinical bovine mastitis in Finland and Israel.
Lehtolainen T; Shwimmer A; Shpigel NY; Honkanen-Buzalski T; Pyörälä S
J Dairy Sci; 2003 Dec; 86(12):3927-32. PubMed ID: 14740828
[TBL] [Abstract][Full Text] [Related]
29. Recovery of ceftazidime-resistant Klebsiella pneumoniae from pediatric liver and intestinal transplant recipients.
Green M; Barbadora K
Pediatr Transplant; 1998 Aug; 2(3):224-30. PubMed ID: 10084747
[TBL] [Abstract][Full Text] [Related]
30. Asymptomatic bacteriuria and symptomatic urinary tract infections (UTI) in patients with diabetes mellitus in Tikur Anbessa Specialized University Hospital, Addis Ababa, Ethiopia.
Yeshitela B; Gebre-Selassie S; Feleke Y
Ethiop Med J; 2012 Jul; 50(3):239-49. PubMed ID: 23409407
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic and genotypic characterization of extended-spectrum b-lactamases producing Escherichia coli and Klebsiella pneumoniaein a tertiary care hospital in Riyadh, Saudi Arabia.
Somily AM; Arshad MZ; Garaween GA; Senok AC
Ann Saudi Med; 2015; 35(6):435-9. PubMed ID: 26657226
[TBL] [Abstract][Full Text] [Related]
32. Influence of subinhibitory concentrations of ceftazidime, ciprofloxacin and azithromycin on the morphology and adherence of P-fimbriated escherichia coli.
Vranes J; Zagar Z; Kurbel S
J Chemother; 1996 Aug; 8(4):254-60. PubMed ID: 8873829
[TBL] [Abstract][Full Text] [Related]
33. Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia.
Karol SE; Sun Y; Tang L; Pui CH; Ferrolino J; Allison KJ; Cross SJ; Evans WE; Crews KR; Jeha S; Wolf J
Cancer Med; 2020 Sep; 9(18):6550-6555. PubMed ID: 32710497
[TBL] [Abstract][Full Text] [Related]
34. [Trends and changes in antimicrobial resistance of clinical isolates from 11 hospitals in Beijing area].
Zhang F; Jin S; Wu Q
Zhonghua Yi Xue Za Zhi; 1997 May; 77(5):327-31. PubMed ID: 9772484
[TBL] [Abstract][Full Text] [Related]
35. Antibacterial prophylaxis with trimethoprim-sulfamethoxazole during induction treatment for acute lymphoblastic leukemia.
Schrøder H; Agger KE; Rosthøj S; Carlsen NT; Schmiegelow K
Dan Med Bull; 2001 Nov; 48(4):275-7. PubMed ID: 11767129
[TBL] [Abstract][Full Text] [Related]
36. Ceftazidime-avibactam activity tested against Enterobacteriaceae isolates from U.S. hospitals (2011 to 2013) and characterization of β-lactamase-producing strains.
Castanheira M; Mills JC; Costello SE; Jones RN; Sader HS
Antimicrob Agents Chemother; 2015; 59(6):3509-17. PubMed ID: 25845862
[TBL] [Abstract][Full Text] [Related]
37. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P
BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844
[TBL] [Abstract][Full Text] [Related]
38. Assessment of antibiotic resistance in Klebsiella pneumoniae exposed to sequential in vitro antibiotic treatments.
Kim J; Jo A; Chukeatirote E; Ahn J
Ann Clin Microbiol Antimicrob; 2016 Dec; 15(1):60. PubMed ID: 27938381
[TBL] [Abstract][Full Text] [Related]
39. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme.
Park CH; Robicsek A; Jacoby GA; Sahm D; Hooper DC
Antimicrob Agents Chemother; 2006 Nov; 50(11):3953-5. PubMed ID: 16954321
[TBL] [Abstract][Full Text] [Related]
40. Empirical treatment in patients with acute obstructive pyelonephritis.
Pasiechnikov S; Buchok O; Sheremeta R; Banyra O
Infect Disord Drug Targets; 2015; 15(3):163-70. PubMed ID: 26321323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
